Switch theme
Sign up to access all valuation multiples
Medika DD operates in the medical distribution industry in Croatia. The company is engaged in the sale, storage, and distribution of human and veterinary medicines, medical products, equipment and dental aids, cosmetics, dietary, hygiene, and other products intended for the healthcare market. The company operates through two main distribution channels: Wholesale and Retail. The majority of its revenue is generated through the Wholesale distribution channel, which represents income generated from supplying products to pharmacies, hospitals, and other customers. The Retail distribution channel consists of its self-owned pharmacies.
1922
1.0K+
Last FY Revenue $983M
Last FY EBITDA $37.3M
$210M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
In the most recent fiscal year, Medika achieved revenue of $983M and an EBITDA of $37.3M.
Medika expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Medika valuation multiples based on analyst estimates| NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|
| Revenue | XXX | $983M | XXX | XXX | XXX |
| Gross Profit | XXX | $77.4M | XXX | XXX | XXX |
| Gross Margin | XXX | 8% | XXX | XXX | XXX |
| EBITDA | XXX | $37.3M | XXX | XXX | XXX |
| EBITDA Margin | XXX | 4% | XXX | XXX | XXX |
| EBIT | XXX | $28.0M | XXX | XXX | XXX |
| EBIT Margin | XXX | 3% | XXX | XXX | XXX |
| Net Profit | XXX | $24.0M | XXX | XXX | XXX |
| Net Margin | XXX | 2% | XXX | XXX | XXX |
| Net Debt | XXX | $29.3M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of July 3, 2025, Medika's stock price is EUR 5100 (or $6021).
Medika has current market cap of EUR 148M (or $174M), and EV of EUR 178M (or $210M).
See Medika trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $210M | $174M | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of July 3, 2025, Medika has market cap of $174M and EV of $210M.
Medika's trades at 0.2x EV/Revenue multiple, and 5.6x EV/EBITDA.
Equity research analysts estimate Medika's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Medika's P/E ratio is not available.
See valuation multiples for Medika and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $174M | XXX | $174M | XXX | XXX | XXX |
| EV (current) | $210M | XXX | $210M | XXX | XXX | XXX |
| EV/Revenue | n/a | XXX | 0.2x | XXX | XXX | XXX |
| EV/EBITDA | n/a | XXX | 5.6x | XXX | XXX | XXX |
| EV/EBIT | n/a | XXX | 7.5x | XXX | XXX | XXX |
| EV/Gross Profit | n/a | XXX | n/a | XXX | XXX | XXX |
| P/E | n/a | XXX | 7.3x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | -4.6x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialMedika's revenue per employee in the last FY averaged $1.0M, while opex per employee averaged $48K for the same period.
Medika's rule of 40 is unknown (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Medika's rule of X is unknown (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Medika and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| EBITDA Margin | n/a | XXX | 4% | XXX | XXX | XXX |
| EBITDA Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | n/a | XXX | n/a | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | n/a | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $1.0M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $48K | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 0% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 5% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Ansell | XXX | XXX | XXX | XXX | XXX | XXX |
| Polymed | XXX | XXX | XXX | XXX | XXX | XXX |
| Farmaceutica Remedia | XXX | XXX | XXX | XXX | XXX | XXX |
| Etropal | XXX | XXX | XXX | XXX | XXX | XXX |
| Sopharma | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Medika acquired XXX companies to date.
Last acquisition by Medika was XXXXXXXX, XXXXX XXXXX XXXXXX . Medika acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Medika founded? | Medika was founded in 1922. |
| Where is Medika headquartered? | Medika is headquartered in Croatia. |
| How many employees does Medika have? | As of today, Medika has 1.0K+ employees. |
| Is Medika publicy listed? | Yes, Medika is a public company listed on ZAG. |
| What is the stock symbol of Medika? | Medika trades under MDKA ticker. |
| When did Medika go public? | Medika went public in 2005. |
| Who are competitors of Medika? | Similar companies to Medika include e.g. Ansell, Polymed, Farmaceutica Remedia, Etropal. |
| What is the current market cap of Medika? | Medika's current market cap is $174M |
| Is Medika profitable? | Yes, Medika is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
